MedPath

TARO-MUPIROCIN

TARO-MUPIROCIN

Approved
DIN Number

02279983

Drug Class

Human

Market Date

Jul 10, 2006

Company
HC

Taro Pharmaceuticals Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02279983
AIG Number0117081001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
D06AX09 MUPIROCIN
Product Specifications
Dosage FormOintment
Route of AdministrationTopical
AHFS Classification84:04.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

MUPIROCINActive
Strength: 2 %
Monograph: MUPIROCIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.